Wound Care (Pharmacies) - North America

  • North America
  • Revenue in the Wound Care market is projected to reach US$1.14bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.35%, resulting in a market volume of US$1.16bn by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.23 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in North America is experiencing significant growth due to several key factors.

Customer preferences:
Customers in North America have shown a strong preference for wound care products that are easy to use and provide effective treatment. They value products that are convenient and can be easily purchased at their local pharmacies. Additionally, customers are increasingly seeking out products that are made from natural ingredients and are environmentally friendly.

Trends in the market:
One of the major trends in the North American wound care market is the increasing demand for advanced wound care products. This is driven by the rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, which require specialized treatment. Advanced wound care products, such as dressings, gels, and creams, are designed to promote faster healing and prevent infection. Another trend in the market is the growing popularity of online pharmacies. Customers are increasingly turning to online platforms to purchase wound care products due to the convenience and accessibility they offer. Online pharmacies provide a wide range of products, competitive pricing, and the ability to compare different brands and options. This trend is expected to continue as more customers become comfortable with online shopping.

Local special circumstances:
In North America, the aging population is a significant factor driving the growth of the wound care market. As the population ages, the prevalence of chronic wounds increases, leading to a higher demand for wound care products. Additionally, the high prevalence of diabetes in the region contributes to the growth of the market, as diabetic patients are more prone to developing chronic wounds. Furthermore, the increasing healthcare expenditure in North America is also fueling the growth of the wound care market. The region has a well-established healthcare infrastructure and a high level of healthcare spending, which allows for better access to wound care products and treatments.

Underlying macroeconomic factors:
The strong economic growth in North America is contributing to the development of the wound care market. As the economy grows, consumers have more disposable income to spend on healthcare products, including wound care. Additionally, the region's stable political environment and favorable regulatory policies create a conducive market environment for the growth of the wound care industry. In conclusion, the Wound Care (Pharmacies) market in North America is experiencing growth due to customer preferences for convenient and effective products, increasing demand for advanced wound care, the rise of online pharmacies, the aging population, increasing healthcare expenditure, and strong macroeconomic factors. These factors are driving the development of the market and are expected to continue to do so in the future.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)